Pigmentary disorders


Depigmentation therapy refers to medical treatments that remove skin pigmentation. Depigmentation therapy is used in someone that has widespread, but incomplete, vitiligo on the face and/or other sites, in an attempt to improve their appearance. The most commonly used depigmenting agent is monobenzyl ether of hydroquinone (MBEH). If the patient cannot tolerate MBEH, or if treatment fails, combination therapies or other treatments may be considered. Depigmentation therapy may be considered in the management of treatment resistant vitiligo affecting more than 50% of the body surface area or affecting cosmetically sensitive, exposed body sites


    Related Conference of Pigmentary disorders

    July 15-16, 2024

    24th European Dermatology Congress

    Paris, France
    August 28-29, 2024

    25th World Dermatology Congress

    Paris, France
    August 28-29, 2024

    7th World Cosmetic and Dermatology Congress

    Paris, France
    September 16-17, 2024

    14th International Conference on Cosmetology and Dermatology

    Zurich, Switzerland
    November 25-26, 2024

    26th World Dermatology and Aesthetic Congress

    Bali, Indonesia
    December 02-03, 2024

    7th International Dermatology and Cosmetology Congress

    Prague, Czech Republic

    Pigmentary disorders Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in